These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 19996249)

  • 21. Inappropriate crying and laughing in Parkinson disease and movement disorders.
    Siddiqui MS; Fernandez HH; Garvan CW; Kirsch-Darrow L; Bowers D; Rodriguez RL; Jacobson CE; Rosado C; Vaidyanathan S; Foote KD; Okun MS
    World J Biol Psychiatry; 2009; 10(3):234-40. PubMed ID: 18609421
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anxiety, depression, and quality of life in Parkinson's disease.
    Quelhas R; Costa M
    J Neuropsychiatry Clin Neurosci; 2009; 21(4):413-9. PubMed ID: 19996250
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes of emotional prosody in Parkinson's disease.
    Schröder C; Nikolova ZT; Dengler R
    J Neurol Sci; 2010 Feb; 289(1-2):32-5. PubMed ID: 19732910
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anhedonia, depression, and motor functioning in Parkinson's disease during treatment with pramipexole.
    Lemke MR; Brecht HM; Koester J; Kraus PH; Reichmann H
    J Neuropsychiatry Clin Neurosci; 2005; 17(2):214-20. PubMed ID: 15939976
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The syndromal validity and nosological position of apathy in Parkinson's disease.
    Starkstein SE; Merello M; Jorge R; Brockman S; Bruce D; Power B
    Mov Disord; 2009 Jun; 24(8):1211-6. PubMed ID: 19412942
    [TBL] [Abstract][Full Text] [Related]  

  • 26. International validation of a behavioral scale in Parkinson's disease without dementia.
    Rieu I; Martinez-Martin P; Pereira B; De Chazeron I; Verhagen Metman L; Jahanshahi M; Ardouin C; Chéreau I; Brefel-Courbon C; Ory-Magne F; Klinger H; Peyrol F; Schupbach M; Dujardin K; Tison F; Houeto JL; Krack P; Durif F
    Mov Disord; 2015 Apr; 30(5):705-13. PubMed ID: 25809278
    [TBL] [Abstract][Full Text] [Related]  

  • 27. AFQ056 in Parkinson patients with levodopa-induced dyskinesia: 13-week, randomized, dose-finding study.
    Stocchi F; Rascol O; Destee A; Hattori N; Hauser RA; Lang AE; Poewe W; Stacy M; Tolosa E; Gao H; Nagel J; Merschhemke M; Graf A; Kenney C; Trenkwalder C
    Mov Disord; 2013 Nov; 28(13):1838-46. PubMed ID: 23853029
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlation between depressive symptoms and nocturnal disturbances in Japanese patients with Parkinson's disease.
    Suzuki K; Miyamoto M; Miyamoto T; Okuma Y; Hattori N; Kamei S; Yoshii F; Utsumi H; Iwasaki Y; Iijima M; Hirata K
    Parkinsonism Relat Disord; 2009 Jan; 15(1):15-9. PubMed ID: 18359262
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Motor impairment, depression, dementia: which forms the impression of disease severity in Parkinson's disease?
    Riedel O; Klotsche J; Wittchen HU;
    Parkinsonism Relat Disord; 2014 Dec; 20(12):1365-70. PubMed ID: 25304858
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Frequency of social phobia and psychometric properties of the Liebowitz social anxiety scale in Parkinson's disease.
    Kummer A; Cardoso F; Teixeira AL
    Mov Disord; 2008 Sep; 23(12):1739-43. PubMed ID: 18661550
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Suicide and suicidal ideation in Parkinson's disease.
    Kostić VS; Pekmezović T; Tomić A; Jecmenica-Lukić M; Stojković T; Spica V; Svetel M; Stefanova E; Petrović I; Dzoljić E
    J Neurol Sci; 2010 Feb; 289(1-2):40-3. PubMed ID: 19737673
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bipolar Spectrum Disorders in Patients With Cerebellar Lesions: A Comparison With Parkinson's Disease.
    Delle Chiaie R; Minichino A; Salviati M; Fiorentini S; Tonini A; Bersani FS; De Michele F; Caredda M; Biondi M
    J Nerv Ment Dis; 2015 Sep; 203(9):725-9. PubMed ID: 26313038
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The independent influence of apathy and depression on cognitive functioning in Parkinson's disease.
    Butterfield LC; Cimino CR; Oelke LE; Hauser RA; Sanchez-Ramos J
    Neuropsychology; 2010 Nov; 24(6):721-30. PubMed ID: 20853956
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Affective Disorder and Functional Status as well as Selected Sociodemographic Characteristics in Patients with Multiple Sclerosis, Parkinson's Disease and History of Stroke.
    Knapik A; Krzystanek E; Szefler-Derela J; Siuda J; Rottermund J; Plinta R; Brzęk A
    Medicina (Kaunas); 2020 Mar; 56(3):. PubMed ID: 32156038
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anxiety rating scales in Parkinson's disease: a validation study of the Hamilton anxiety rating scale, the Beck anxiety inventory, and the hospital anxiety and depression scale.
    Leentjens AF; Dujardin K; Marsh L; Richard IH; Starkstein SE; Martinez-Martin P
    Mov Disord; 2011 Feb; 26(3):407-15. PubMed ID: 21384425
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Personality characteristics of depressed and non-depressed patients with Parkinson's disease.
    Damholdt MF; Callesen MB; Møller A
    J Neuropsychiatry Clin Neurosci; 2014; 26(4):329-34. PubMed ID: 24817440
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cognitive correlates of visual hallucinations in dementia associated with Parkinson's disease.
    Bronnick K; Emre M; Tekin S; Haugen SB; Aarsland D
    Mov Disord; 2011 Apr; 26(5):824-9. PubMed ID: 21437985
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early phenotypic differences between Parkinson's disease patients with and without freezing of gait.
    Hall JM; Shine JM; Walton CC; Gilat M; Kamsma YP; Naismith SL; Lewis SJ
    Parkinsonism Relat Disord; 2014 Jun; 20(6):604-7. PubMed ID: 24679901
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of the dopamine agonist pramipexole on depression, anhedonia and motor functioning in Parkinson's disease.
    Lemke MR; Brecht HM; Koester J; Reichmann H
    J Neurol Sci; 2006 Oct; 248(1-2):266-70. PubMed ID: 16814808
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Validity of Hamilton Depression Inventory in Parkinson's disease.
    Dissanayaka NN; Sellbach A; Matheson S; Marsh R; Silburn PA; O'Sullivan JD; Byrne GJ; Mellick GD
    Mov Disord; 2007 Feb; 22(3):399-403. PubMed ID: 17230471
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.